Clinical Trials Logo

Clinical Trial Summary

To assess psychiatric, social and sexual consequences of female genital mutilation on married women.


Clinical Trial Description

World Health Organization (WHO) defined female genital mutilation (FGM) as ''all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons. Many countries throughout the globe perform it: Western, Eastern, and North-Eastern Africa, particularly Egypt and Ethiopia, and in parts of Asia and the Middle East (nearly half of its cases are in Egypt and Ethiopia). Moreover, the prevalence of girls and women with FGM/C is also rising in Western countries due to migration flows. The adverse physical consequences of female genital mutilation/cutting (FGM/C) have been thoroughly investigated and documented. Yet, we know little about the adverse mental health consequences of the practice. Also, few systematic reviews have addressed the impact of the practice on psycho-social well-being, and there is limited understanding of what these consequences might consist. Throughout Egypt, many studies have been conducted to determine the pattern and prevalence of FGM, but those studied the risks of FGM and its effect on women's sexual life are scare. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06027281
Study type Observational
Source Assiut University
Contact Mariam Gamil Kamel
Phone +20 01220133561
Email Mariam.20134348@med.aun.edu.eg
Status Not yet recruiting
Phase
Start date November 1, 2023
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04802330 - PREVALENCE OF FEMALE GENITAL MUTILATION IN BENI-SUEF LOCALITIES